Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 250 of 283 entries
View as:

CD19/BCMA CAR-T Cell Therapy for Refractory/Moderate-to-severe Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT06349343 Org: User:
Start: 02/10/25 End: 01/31/27 Due: 01/31/28

A Study of Neoadjuvant TCHpy（Pyrotinib ，Trastuzumab，Carboplatin and Paclitaxel）for ER+/HER2+ Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06000917 Org: User:
Start: 05/11/23 End: 05/11/28 Due: 05/11/29

Effect of Compound Sodium Chlorate and Aminophylline Tablets on Chronic Obstructive Pulmonary Disease(COPD).

Phase: N/A Priority: Normal
NCT ID: NCT04101500 Org: User:
Start: 04/01/19 End: 12/30/24 Due: 12/30/25

Alterations of Gut Microbiota and Serum Biochemical Markers in DILI Patients

Phase: N/A Priority: Normal
NCT ID: NCT05465642 Org: User:
Start: 07/04/22 End: 12/31/24 Due: 12/31/25

Using TEE to Evaluate the Effect of Levosimendan on Patients With ARDS Associated With RVD During MV

Phase: N/A Priority: Normal
NCT ID: NCT05768230 Org: User:
Start: 03/22/23 End: 12/01/25 Due: 12/01/26

Esketamine Induction Intubation in ICU Patients.

Phase: N/A Priority: Normal
NCT ID: NCT05464979 Org: User:
Start: 08/01/22 End: 06/30/24 Due: 06/30/25

Monitorings the Physiological Mechanism of Airway Pressure Release Ventilation in ARDS Patients by EIT

Phase: N/A Priority: Normal
NCT ID: NCT05406427 Org: User:
Start: 03/01/22 End: 03/01/24 Due: 03/01/25

Study of the Diagnostic Value of Hybrid PET/MR and PET/CT in Neuroendocrine Diseases and Tumor Induced Osteomalacia

Phase: N/A Priority: Normal
NCT ID: NCT04045834 Org: User:
Start: 05/05/19 End: 12/31/23 Due: 12/31/24

Study on the Recovery of Pulmonary Function, Chest CT, Airway Microbiota, Hematologic, and Immune & Inflammatory Conditions in COVID-19 Rehabilitation Patients

Phase: N/A Priority: Normal
NCT ID: NCT04456101 Org: User:
Start: 06/19/20 End: 12/12/23 Due: 12/12/24

A Trial of SHR-1316 Maintenance Therapy for Limited Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04647357 Org: User:
Start: 11/27/20 End: 12/27/23 Due: 12/27/24

Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy, HLX07and Serplulimab in LARC

Phase: N/A Priority: Normal
NCT ID: NCT06542588 Org: User:
Start: 07/19/24 End: 12/31/26 Due: 12/31/27

CD19 & CD20 Bispecific CAR T Cells for Relapsed / Refractory B Cell Hematological Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06503094 Org: User:
Start: 01/14/24 End: 06/18/26 Due: 06/18/27

SHR-A1811 and THPy in First or Second Line for HER2 Positive Advanced Breast Cancer Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT06975475 Org: User:
Start: 06/01/25 End: 06/01/28 Due: 06/01/29

(Withdrawal) AI-Based Low-Dose 3D-DSA Reconstruction

Phase: N/A Priority: Normal
NCT ID: NCT06769867 Org: User:
Start: 04/15/25 End: 05/31/25 Due: 05/31/26

Molecular Study and Precision Medicine for Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05883683 Org: User:
Start: 10/01/24 End: 07/01/26 Due: 07/01/27

Anti-CD7 CAR-Engineered T Cells for T Lymphoid Malignancies Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT04823091 Org: User:
Start: 04/15/21 End: 04/07/24 Due: 04/07/25

Study on Glucocorticoid Combined With Gamma Globulin and Ropristine N01 in Treatment of Initial Severe ITP

Phase: N/A Priority: Normal
NCT ID: NCT06686927 Org: User:
Start: 11/20/24 End: 12/20/25 Due: 12/20/26

A Study of LCAR-AIO in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT06653556 Org: User:
Start: 01/08/25 End: 09/30/29 Due: 09/30/30

The Development of Diagnosis and Prognosis Predictive Model for Peripheral Nerve Disease

Phase: N/A Priority: Normal
NCT ID: NCT06843642 Org: User:
Start: 01/01/15 End: 01/01/25 Due: 01/01/26

Monitoring the Efficacy of Duvalizumab Combined With Neoadjuvant Chemotherapy for Ib-IIIb NSCLC by Sequencing of Immune Receptor Repertoire: a Prospective, One Arm Clinical Study

Phase: N/A Priority: Normal
NCT ID: NCT04897386 Org: User:
Start: 06/01/21 End: 12/01/24 Due: 12/01/25

Long-term Sedation With Remimazolam Besylate in Critically Ill Patients

Phase: N/A Priority: Normal
NCT ID: NCT05555667 Org: User:
Start: 05/16/23 End: 12/01/25 Due: 12/01/26

Reducing Excision Margins After Neoadjuvant Chemoimmunotherapy for HPV Negative Resectable Locally Advanced HNSCC

Phase: N/A Priority: Normal
NCT ID: NCT05459415 Org: User:
Start: 06/22/22 End: 06/21/27 Due: 06/21/28

The Safety, Efficacy, and Cellular Metabolic Kinetics of CT1192 in Treating Patients With Anti Neutrophil Cytoplasmic Antibody Associated Vasculitis

Phase: N/A Priority: Normal
NCT ID: NCT07033299 Org: User:
Start: 07/01/25 End: 03/31/27 Due: 03/31/28

Safety and Efficacy of Anti-CD123 CAR-T Therapy in Patients With Refractory/ Relapsed CD123+ Acute Myeloid Leukemia.

Phase: N/A Priority: Normal
NCT ID: NCT04014881 Org: User:
Start: 07/06/19 End: 07/01/22 Due: 07/01/23

The Diagnostic Value of Hybrid PET/MR for Systemic Amyloidosis

Phase: N/A Priority: Normal
NCT ID: NCT04006223 Org: User:
Start: 03/11/19 End: 12/31/23 Due: 12/31/24